Status:
COMPLETED
Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
TrygFonden, Denmark
Conditions:
Anemia
Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the postoperative ambulation.
Eligibility Criteria
Inclusion
- 18 years or older
- Patients undergoing replacement of hip arthroplasty
- Be legally competent
- Read and understand Danish
Exclusion
- Present malignant disease
- Known heart disease with functionality equivalent to NYHA II or CCS II or worse
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00906295
Start Date
June 1 2009
End Date
June 1 2011
Last Update
June 6 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400
2
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Østerbro, Denmark, 2100